T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ross Stores
ROST
$79.6B
| $5.75B | 0.58% |
47,931,712
-37,024
| -0.1% | -$4.39M |
|
|
27
Morgan Stanley
MS
$342B
| $5.35B | 0.54% |
68,938,163
-29,471,039
| -30% | -$2.26B |
|
|
SCHW
28
Charles Schwab
SCHW
$189B
| $5.26B | 0.53% |
80,736,724
-4,337,011
| -5% | -$263M |
|
29
Roper Technologies
ROP
$39.1B
| $5.18B | 0.52% |
12,850,531
+65,220
| +0.5% | +$26.2M |
|
30
Thermo Fisher Scientific
TMO
$223B
| $5.1B | 0.51% |
11,183,061
-1,379,329
| -11% | -$658M |
|
31
Wells Fargo
WFC
$269B
| $5.04B | 0.5% |
128,990,462
+22,458,740
| +21% | +$795M |
|
|
32
Eli Lilly
LLY
$1.09T
| $4.89B | 0.49% |
26,155,001
+14,060,388
| +116% | +$2.75B |
|
33
Bank of America
BAC
$453B
| $4.85B | 0.49% |
125,457,129
-5,969,855
| -5% | -$206M |
|
34
Elevance Health
ELV
$86.6B
| $4.55B | 0.46% |
12,686,564
+715,968
| +6% | +$230M |
|
35
HCA Healthcare
HCA
$89.8B
| $4.42B | 0.44% |
23,474,336
-1,686,405
| -7% | -$297M |
|
36
Applied Materials
AMAT
$435B
| $4.37B | 0.44% |
32,705,235
-13,432,113
| -29% | -$1.48B |
|
37
Goldman Sachs
GS
$302B
| $4.37B | 0.44% |
13,349,759
-90,768
| -0.7% | -$28.3M |
|
38
Booking.com
BKNG
$159B
| $4.25B | 0.43% |
45,626,700
-1,967,875
| -4% | -$175M |
|
39
Humana
HUM
$46.7B
| $4.23B | 0.42% |
10,089,140
+99,832
| +1% | +$39.9M |
|
40
Match Group
MTCH
$8.4B
| $4.21B | 0.42% |
30,676,700
-4,128,036
| -12% | -$620M |
|
|
MRSH
41
Marsh
MRSH
$90.1B
| $4.15B | 0.42% |
34,056,089
+1,002,874
| +3% | +$115M |
|
|
42
Zoom
ZM
$30.8B
| $4.03B | 0.4% |
12,537,274
+8,964,122
| +251% | +$3.3B |
|
43
Walt Disney
DIS
$178B
| $3.91B | 0.39% |
21,179,052
+1,685,039
| +9% | +$311M |
|
44
Linde
LIN
$221B
| $3.84B | 0.38% |
13,715,094
+75,543
| +0.6% | +$19.6M |
|
|
45
NVIDIA
NVDA
$5.43T
| $3.81B | 0.38% |
285,681,760
-134,579,840
| -32% | -$1.81B |
|
46
Yum! Brands
YUM
$41B
| $3.69B | 0.37% |
34,084,064
+3,464,493
| +11% | +$367M |
|
47
Dollar General
DG
$26.4B
| $3.64B | 0.36% |
17,971,130
-2,511,249
| -12% | -$499M |
|
48
PNC Financial Services
PNC
$102B
| $3.62B | 0.36% |
20,653,134
-5,738,620
| -22% | -$947M |
|
49
Nike
NKE
$60.1B
| $3.57B | 0.36% |
26,861,087
-2,439,801
| -8% | -$339M |
|
50
Vertex Pharmaceuticals
VRTX
$133B
| $3.56B | 0.36% |
16,549,876
-3,077,048
| -16% | -$676M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.